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Background: Increased survival in CF patients (pts) requires assessment of extra-
pulmonary morbidities, as SD. Scoliosis (S) is more frequent in CF than in general
population; it causes functional spinal disorders and restrictive pulmonary disease
and may be inﬂuenced by CF musculoskeletal involvement.
Aims: To describe:
• SD distribution in a group of CF pts
• SD and clinical status relationship
• 2 years follow up in a subgroup
Methods: Respiratory therapist measured the angle of trunk rotation (ATR)
with scoliometer in the Adams forward bending test position in CF pts,
6−19 years old (yrs).
Results: 58 pts (M 46.55%, aged 12.45±3.61 yrs, median %ile for weight 39.22
and for height 49.12, mean FEV1 91.79±16.94%pred) were enrolled. No difference
at baseline existed between males and females. Pts were divided in: (1) Negative
group (N): ATR 0−4º (n = 48); (2) Positive group (P): ATR 5º (n = 10). Pts in P
were older (p = 0.001); N had greater FVC%pred (p = 0.008). 6 thoracic (60%),
3 lumbar (30%) and 1 thoracolumbar (10%) curves (70% with right convexity) were
found. Specialized physician prescribed 10 spine x-ray diagnosing S (>10º Cobb)
in 3 pts (5.17%) with indication of brace. ATR correlated with height %ile (r = 0.7;
p = 0.02) in P; no relationship with lung function was found. 36 pts were reassessed
2 years after the 1st evaluation. ATR was the same in 52.78% of pts, while it
increased in 25%. Changes in ATR didn’t correlate with respiratory and nutritional
status.
Conclusion: Our data justify SD early screening and at least yearly reassessment
because of their possible progression and lack of correlation with clinical data.
A study to assess S and back pain prevalence in adult CF pts is ongoing.
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Objectives: Treatment for chronic M. abscessus infection comprises maintenance
therapy with oral and nebulised antibiotics, coupled with periodic exacerbation
therapy with IV antibiotics. Typically lung function and weight gain improves with
treatment of exacerbations, and there is interval loss in lung function and weight
while on maintenance therapy. We report a case of an adolescent with chronic
symptomatic M. abscessus infection, who needs hospital admission 2−3 monthly to
sustain lung function. Severe nausea and vomiting has complicated IV treatment and
so some admissions are limited to aggressive airway clearance and nutritional review
without IV antibiotics. We sought to compare outcomes between those admissions
with and without IV antibiotic therapy.
Methods: We retrospectively analysed weight and lung function proﬁles over
15 months and across 6 hospital admissions.
Results: For admissions involving IV antibiotic therapy, we identiﬁed a paradoxical
pattern of improvement in lung function with loss of weight, as a consequence of
nausea and vomiting during treatment. Catch up in weight was seen between hospital
admssions. Admissions for MDT support without IV antibiotics showed equivalent
beneﬁts in lung function, but also demonstrated good weight gain.
Conclusion: In patients who require frequent admissions for chest exacerbations,
antibiotic tolerance and drug toxicity represent barriers to treatment which need
careful consideration. Introducing short admissions for MDT support without
IV antibiotic therapy can produce equivalent improvements in lung function and
weight gain and can be used to extend periods between toxic IV antibiotic
treatments.
